Kidney Cancer Medical Malpractice Lawyer Compensation Claims



Legal Helpline 855-804-7142



Thousands of Canadian citizens are diagnosed with kidney cancer every year. The key to survival is early diagnosis and treatment which is often delayed due to misdiagnosis or misinterpreted test results. Kidney cancer misdiagnosis is extremely common and failure by a healthcare practitioner that amounts to negligence is a matter of medical malpractice and entitles the victim to claim financial recompense for pain and suffering or the loss of opportunity for a cure. Our specialist medical malpractice lawyers deal with kidney cancer clinical negligence cases against doctors, nurses, technicians and other healthcare providers working in medical practices, clinics, hospitals and all other places where health care is dispensed. If you would like advice about kidney cancer misdiagnosis just contact our offices and a specialist medical malpractice lawyer with call to discuss your potential compensation claim without charge and without further obligation. Our medical malpractice lawyers will give you their opinion on the liability of the negligent healthcare provider and will estimate the amount of the likely award of damages there and then.

Kidney Cancer Misdiagnosis Facts

Kidney cancer is a cancer that affects the cells of the kidney. These cells undergo changes in their DNA so that they grow out of control. About 4,000 individuals will be diagnosed with kidney cancer (renal carcinoma) in Canada each year. Almost twice as many men have kidney cancer as women. About 1200 individuals die from kidney cancer each year. The average age at diagnosis is 65 years of age. The average age at death from renal cancer is 71 years. About 4.2 per 100,000 people die each year of kidney cancer. The rate is twice as much in men as in women.

The overall survival rate of kidney cancer is 65 percent. This is after five years. The stage of the cancer relates to the rate of survival. Fifty three percent of cases are fortunately diagnosed when the person has localized cancer, which has the highest survival rate. Twenty percent of individuals are diagnosed when the cancer has already spread to lymph nodes or beyond the border of the kidney. Another 22 percent of cases are diagnosed when the disease is metastatic, which carries the worst prognosis. While 91 percent of patients are alive after five years who have had localized disease, only 10 percent of those with metastatic disease are alive after five years.

The risk factors for getting renal cell cancer include having a family history of the disease, being on dialysis, having high blood pressure, having a horseshoe kidney and smoking. A genetic disease called Von Hippel-Lindau disease predisposes a person to having renal cell cancer.

The major symptoms of renal cell cancer include having flank pain in the area of the kidneys, abdominal pain, blood in the urine, low back pain, a varicocele (in men only), and having unintentional weight loss. The abdomen can swell or become enlarged when fluid builds up in the abdomen from kidney failure. Less commonly, symptoms can include constipation, excessive hair growth in women, cold intolerance, paleness and visual disturbances. The cancer can metastasize to abdominal organs, most commonly the other kidney so that both kidneys are involved.

Doctors can diagnose kidney cancer by a complete history and physical examination. An abdominal CT scan or MRI scan can show the tumor in the kidney. A CBC can show anemia typical of the condition and an IVP or intravenous pyelogram can use dye to show up defects in the kidneys seen in renal cell carcinoma. Renal arteriography can be done instead of an IVP to show kidney cancer. A percutaneous biopsy or an open biopsy can be done to show the kidney cancer under the microscope. Bone scans, chest x-rays and PET scans can be good tests to stage the cancer and find any metastases that might be present.

The treatment of renal cell cancer involves removing all or a portion of the kidney to remove all of the cancer. This can greatly increase the survival rate. The bladder may have to be removed in advanced cases as well as the surrounding lymph nodes. Some metastases can be removed in an open abdominal procedure so that the patient has the best chance of survival.

Radiation therapy doesn’t usually work for renal cell carcinoma so doctors don’t often use it. There is hormonal therapy available for renal cell cancer that seems to work in some individuals. Unfortunately, chemotherapy is not very helpful in renal cancer. This highlights the reason behind getting as many metastases as can be surgically removed. Biologic therapies such as Nexavar, Sutent and Torisel have been extremely helpful in the treatment of renal cell cancer. It is unlikely to cure the kidney cancer unless all of the cancer is removed surgically. The rest of the treatments are primarily palliative.

Legal Helpline 855-804-7142